Zain Maryam, Awan Fazli Rabbi, Amir Sidra, Baig Shahid Mahmood
Diabetes and Cardio-Metabolic Disorder (D&C-MD) Laboratory, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Jhang Road, P.O. Box.577, Faisalabad, Pakistan ; Pakistan Institute of Engineering and Applied Sciences (PIEAS), Islamabad, Pakistan.
J Diabetes Metab Disord. 2015 May 6;14:40. doi: 10.1186/s40200-015-0166-x. eCollection 2015.
The Catechol-O-Methyl Transferase (COMT) gene polymorphism (I/D of C nucleotide at base position 900) has been previously implicated in the development of type 2 diabetes (T2D) and kidney disease. So, aim of this study was to find association of I/D polymorphism with T2D, and its associated factors like family history and nephropathy (End Stage Renal Disease, ESRD) patients in a cohort of Pakistani Punjabis.
Genomic DNA was extracted from human subjects divided as four study groups: controls (n = 46), diabetics (n = 46), diabetics with nephropathy/ESRD (n = 53), and non-diabetics without nephropathy/ESRD (n = 43). The 900 I/D C polymorphism in the COMT gene was tested by PCR-RFLP method. Genotype and allele frequencies as well as Odds Ratios were calculated for these groups. Groups were compared statistically for the analysis of genotypes, alleles, biochemical parameters as well as disease status.
In comparison with control group (non-diabetic, non-nephropathy), there was no significant difference in rest of the three groups for allele or genotype frequencies of COMT gene. However, Chi square (χ(2)) analysis identified a significant (p = 0.02) correlation of the 900 I/D C polymorphism with family history of diabetes, as it was found that greater number (74%) of patients having I allele had a positive family history of T2D.
A significant correlation of the COMT polymorphism (900 I/D C) with the family history of T2D has been observed, which has not been previously reported in Pakistani Punjabi population, however, this preliminary finding requires further validation studies.
儿茶酚-O-甲基转移酶(COMT)基因多态性(第900位碱基C的I/D)先前已被认为与2型糖尿病(T2D)和肾脏疾病的发生有关。因此,本研究的目的是在一组巴基斯坦旁遮普人群中,寻找I/D多态性与T2D及其相关因素(如家族史和肾病患者(终末期肾病,ESRD))之间的关联。
从人类受试者中提取基因组DNA,将其分为四个研究组:对照组(n = 46)、糖尿病患者(n = 46)、患有肾病/ESRD的糖尿病患者(n = 53)和无肾病/ESRD的非糖尿病患者(n = 43)。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法检测COMT基因中900 I/D C多态性。计算这些组的基因型和等位基因频率以及优势比。对各组的基因型、等位基因、生化参数以及疾病状态进行统计学比较分析。
与对照组(非糖尿病、无肾病)相比,其他三组COMT基因的等位基因或基因型频率无显著差异。然而,卡方(χ(2))分析发现900 I/D C多态性与糖尿病家族史存在显著相关性(p = 0.02),因为发现携带I等位基因的患者中,有较大比例(74%)有T2D家族史阳性。
观察到COMT多态性(900 I/D C)与T2D家族史存在显著相关性,这在巴基斯坦旁遮普人群中尚未见先前报道,然而,这一初步发现需要进一步的验证研究。